LYDIA FRY: Open Payments
NPI 1245897933 · NEWVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 12 companies in 2025. Trend: 2023 $397 · 2024 $110 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $53 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: UBRELVY, SHINGRIX, VRAYLAR, XIFAXAN, BEXSERO, PROQUAD, EVENITY, ELIQUIS.
Industry payments across PA — which companies pay providers there.
